We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Cabot Corp
CBT
$4.65B
| $417K | ﹤0.01% |
+8,622
| New | +$371K |
|
877
Darden Restaurants
DRI
$22.5B
| $409K | ﹤0.01% |
6,170
-425,581
| -99% | -$26.9M |
|
878
KB Home
KBH
$3.48B
| $408K | ﹤0.01% |
28,605
-281,554
| -91% | -$3.29M |
|
|
ONCE
879
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $405K | ﹤0.01% |
+13,738
| New | +$433K |
|
|
ISLE
880
DELISTED
Isle of Capri Casinos Inc
ISLE
| $401K | ﹤0.01% |
+28,651
| New | +$353K |
|
881
Plains GP Holdings
PAGP
$5.23B
| $397K | ﹤0.01% |
17,151
| – | – |
|
882
Huntington Bancshares
HBAN
$35.1B
| $391K | ﹤0.01% |
40,985
-676
| -2% | -$6.23K |
|
|
BRFS
883
DELISTED
BRF SA
BRFS
| $387K | ﹤0.01% |
27,194
+10,112
| +59% | +$134K |
|
884
New Jersey Resources
NJR
$6.06B
| $387K | ﹤0.01% |
+10,630
| New | +$368K |
|
|
WLL
885
DELISTED
Whiting Petroleum Corporation
WLL
| $387K | ﹤0.01% |
162
-285
| -64% | -$560K |
|
886
Agios Pharmaceuticals
AGIO
$2.16B
| $385K | ﹤0.01% |
+9,474
| New | +$405K |
|
|
ACOR
887
DELISTED
Acorda Therapeutics
ACOR
| $382K | ﹤0.01% |
+120
| New | +$498K |
|
888
Tanger
SKT
$4.82B
| $380K | ﹤0.01% |
+10,450
| New | +$344K |
|
889
Equinix
EQIX
$107B
| $379K | ﹤0.01% |
1,145
-532
| -32% | -$162K |
|
890
Las Vegas Sands
LVS
$30.5B
| $378K | ﹤0.01% |
+7,315
| New | +$335K |
|
|
CIT
891
DELISTED
CIT Group Inc.
CIT
| $377K | ﹤0.01% |
12,134
+2,283
| +23% | +$71.9K |
|
|
HBI
892
DELISTED
Hanesbrands
HBI
| $375K | ﹤0.01% |
13,249
-223,385
| -94% | -$6.39M |
|
893
Pearson
PSO
$9.78B
| $372K | ﹤0.01% |
29,629
-49,684
| -63% | -$568K |
|
|
XENT
894
DELISTED
Intersect ENT, Inc
XENT
| $369K | ﹤0.01% |
+19,400
| New | +$351K |
|
895
Comscore
SCOR
| $367K | ﹤0.01% |
611
-4,997
| -89% | -$3.61M |
|
|
BKI
896
DELISTED
Black Knight, Inc. Common Stock
BKI
| $367K | ﹤0.01% |
+11,830
| New | +$347K |
|
|
QUNR
897
DELISTED
Qunar Cayman Islands Limited
QUNR
| $367K | ﹤0.01% |
+9,234
| New | +$356K |
|
898
Apogee Enterprises
APOG
$850M
| $365K | ﹤0.01% |
+8,322
| New | +$330K |
|
899
Martin Midstream Partners
MMLP
$95.9M
| $365K | ﹤0.01% |
+18,190
| New | +$315K |
|
900
Textron
TXT
$16.6B
| $363K | ﹤0.01% |
9,953
-18,345
| -65% | -$643K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.